The compliance and revenue benefits of ProHeart Vs monthly heartworm disease preventives in the US

The aim of the current study was to understand how the canine heartworm disease preventive ProHeart® 12 (extended-release injectable moxidectin, PH 12), impacts heartworm preventive purchase compliance and veterinary practice revenue over time compared to monthly heartworm disease preventives. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwacalimba, Kennedy, Smith, Kristine, Moldavchuk, Marina, Sears, Derek, Brennan, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371284/
https://www.ncbi.nlm.nih.gov/pubmed/35951635
http://dx.doi.org/10.1371/journal.pone.0271058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371284/
https://www.ncbi.nlm.nih.gov/pubmed/35951635
http://dx.doi.org/10.1371/journal.pone.0271058

Ejemplares similares